Related Experiment Video
Updated: May 1, 2026

07:31
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
6.9K
A cluster-randomised controlled feasibility trial evaluating the Cognitive Occupation-Based programme for people with
Sinéad M Hynes1, Christopher P Dwyer2, Alberto Alvarez-Iglesias3
1Discipline of Occupational Therapy, School of Health Sciences, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland.
Summary
The Cognitive Occupation-Based programme for Multiple Sclerosis (COB-MS) is a feasible and effective intervention for improving daily functioning in people with MS. This study supports further testing of COB-MS in a definitive trial.
Area of Science:
- Neuroscience
- Rehabilitation Science
- Occupational Therapy
Background:
- Cognitive difficulties are prevalent in Multiple Sclerosis (MS), impacting daily life.
- Existing cognitive programs often lack focus on functional, everyday living skills.
- The Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS) was developed to address these gaps.
Purpose of the Study:
- To evaluate the feasibility and initial efficacy of the COB-MS intervention.
- To assess COB-MS as a cognitive intervention for individuals with MS.
- To determine if COB-MS meets progression criteria for a definitive trial.
Main Methods:
- A cluster-randomised controlled feasibility trial was conducted.
- The COB-MS intervention was delivered remotely by occupational therapists over eight sessions.
- Data on cognition, quality of life, mood, and functional outcomes (Goal Attainment Scaling) were collected at multiple time points.
Main Results:
- 118 participants with MS and cognitive difficulties were randomized (58 to COB-MS, 60 to usual care).
- The COB-MS intervention was found to be feasible, acceptable to participants, and demonstrated positive impacts on daily life.
- A significant improvement in the primary outcome (Goal Attainment Scaling) was observed in the COB-MS group compared to the control group.
Conclusions:
- The feasibility trial met its progression criteria, supporting further investigation.
- Results provide a strong basis for a definitive trial of COB-MS.
- The COB-MS shows preliminary clinical efficacy for individuals with MS experiencing cognitive challenges.

